IMPACT BIOMEDICAL INC
IBO·45259L205·US·Common Stock·Healthcare - Biotechnology-Activist
IBO (IMPACT BIOMEDICAL INC) is held by 15 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($716,246), VANGUARD CAPITAL MANAGEMENT LLC ($424,901), STATE STREET CORP ($364,738). Net institutional sentiment: Mixed.
15
Holders
Avg rating(3 Elite)
$2.2M
Total Value
59% (21)
Fund Consensus
10 buying - 7 selling
Who's Trading
InsiderMDMacko Todd DSell $24KMar 27, 2026
InsiderMDMacko Todd DSell $961.28Mar 25, 2026
InsiderGJGrady JasonSell $33KMar 23, 2026
InsiderDIDSS, INC.Sell $25KMay 27, 2025
InsiderDIDSS, INC.Sell $63KMay 22, 2025
ActivistHFHeng Fai Ambrose Chan2.9%Apr 4, 2025
InsiderDIDSS, INC.Sell $845KApr 4, 2025
InsiderCAChan Heng Fai AmbroseSell $173KApr 4, 2025
InsiderCAChan Heng Fai AmbroseSell $174KApr 3, 2025
InsiderCAChan Heng Fai AmbroseSell $213KApr 3, 2025
13F: Insider & Congress:
Showing 1-20 of 21
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer